DEF 14C: Ontrak Secures Additional Funding Through Debt and Equity Agreements
DEF 14C Filing
Ontrak announces a series of financial maneuvers, including debt amendments and potential equity issuances, aimed at bolstering its capital structure and satisfying Nasdaq listing requirements.
Summary
- Ontrak has entered into a Sixth Amendment to its Keep Well Agreement with Acuitas Capital, potentially allowing for the issuance of up to $15 million in senior secured convertible promissory notes.
- The company issued an Initial Demand Note of $1.5 million on April 5, 2024.
- Acuitas has the option to purchase up to an additional $13.5 million in Demand Notes.
- The Sixth Amendment includes provisions for issuing Demand Warrants and New Keep Well Warrants, subject to stockholder approval.
- The conversion price of the Surviving Note will be amended to the lesser of $0.36 or a floating market-based price, also subject to stockholder approval.
- Ontrak is seeking stockholder approval to comply with Nasdaq listing rules regarding the issuance of these securities.
- The company's common stock may be delisted by Nasdaq if it fails to maintain a minimum bid price, though Ontrak believes it is eligible for an extension period to regain compliance.
- Certain warrants contain price protection in the form of anti-dilution provisions that could harm trading in Ontrak's common stock and make it difficult to obtain additional financing.
Sentiment
Score: 5
Explanation: The document presents a mixed sentiment. While it highlights potential funding opportunities and cost-saving measures, it also acknowledges significant financial challenges, including past losses, dependence on key customers, and potential delisting from Nasdaq. The overall tone is cautiously optimistic, but the presence of numerous risks and uncertainties tempers the positive aspects.
Positives
- The Sixth Amendment provides Ontrak with potential access to additional capital.
- The company is taking steps to comply with Nasdaq listing rules.
- The company has expanded its program to a larger commercial population with a health plan customer, one of the largest health systems in the U.S. Mid-Atlantic and Southeast.
- The expanded partnership initially represents a more than 6.5 times increase in the number of this customer's members who are eligible for the Ontrak WholeHealth+ program.
Negatives
- The company has incurred significant losses since its inception and may be unable to obtain additional funds before achieving positive cash flows.
- The company's business currently depends upon a few large customers, and the loss of a large customer would have a material adverse effect on the company.
- The company has $3.5 million in principal amount of secured debt outstanding under the Keep Well Agreement, $1.5 million of which is payable upon demand of the lender, and a default thereunder would have material adverse consequences to the company's financial condition, operating results, and business.
- The company's common stock may be delisted by Nasdaq.
- Certain warrants contain price protection in the form of anti-dilution provisions that could harm trading in Ontrak's common stock and make it difficult for us to obtain additional financing.
Risks
- The company's programs may not be as effective as believed, limiting potential revenue growth.
- The company may be unable to compete successfully in a highly competitive industry.
- The company depends on key personnel, and their loss could impact the ability to manage the business.
- The company may be unable to protect its intellectual property rights.
- Ongoing healthcare legislative and regulatory reform measures may have a material adverse effect on the company's business and results of operations.
- The company's largest stockholder controls a significant portion of the outstanding common stock and may determine all matters presented for stockholder approval.
- The company is subject to ongoing litigation and may be subject to future litigation, any of which could result in substantial liabilities.
Future Outlook
The company expects its cash on hand, together with proceeds from warrant exercises and potential borrowings, will be sufficient to meet obligations for at least the next 12 months. Management plans to continue executing its strategy to increase liquidity by exploring other sources of capital, managing operating costs, and pursuing growth strategies.
Industry Context
The document highlights the competitive nature of the healthcare and behavioral health treatment industries, with Ontrak competing against larger organizations with greater resources. The company emphasizes its unique approach to behavioral healthcare, integrating AI services into every step of a member's journey.
Related Party Transactions
- The Sixth Amendment to the Keep Well Agreement is a related party transaction with Acuitas Capital, an entity indirectly wholly owned and controlled by Terren S. Peizer, the company's former Chief Executive Officer and Chairman.
Stakeholder Impact
- The issuance of new shares and warrants will dilute the percentage interest of existing shareholders.
- The company's ability to continue operations and execute its growth strategy depends on securing additional funding.
- The potential delisting from Nasdaq could negatively impact the liquidity and value of the company's stock.
Next Steps
- Seek stockholder approval for the Sixth Amendment and related actions.
- File a preliminary and definitive information statement with the SEC.
- Potentially implement a reverse stock split to regain compliance with Nasdaq listing rules.
- Continue to execute on growth strategy by expanding sales and marketing resources, improving market penetration, leveraging AI technology, and pursuing partnerships.
Key Dates
| Date | Description |
|---|---|
| April 15, 2022 | Date of the original Master Note Purchase Agreement (Keep Well Agreement). |
| March 28, 2024 | Date of the Sixth Amendment to the Keep Well Agreement. |
| April 5, 2024 | Date the Company issued the Initial Demand Note. |
| April 19, 2024 | Record date for stockholders entitled to notice of actions taken by written consent. |
| April 22, 2024 | Date of Stockholder Consent approving the Corporate Actions. |
| May 13, 2024 | Approximate date of first mailing of the information statement to stockholders. |
| June 2, 2024 | Approximate effective date of stockholder approval of the Corporate Actions. |
| May 14, 2026 | Date of potential adjustment to the exercise price of the warrants. |
| June 20, 2027 | Date prior to which certain warrant adjustments may occur. |
Keywords
Acuitas Capital, Demand Notes, Demand Warrants, Keep Well Agreement, Nasdaq, Stockholder Approval, Convertible Notes, Warrants, Financing, Debt, Equity, Ontrak
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.